Cipla reports 26% rise in Q3 net profit

06 Feb 2013 Evaluate

Cipla has reported results for third quarter ended December 31, 2012.

The company has reported 25.51% rise in its net profit at Rs 338.78 crore for the quarter as compared to Rs 269.91 crore for the same quarter in the previous year. Total income of the company has increased by 18.33% at Rs 2123.97 crore for quarter under review as compared to Rs 1794.95 crore for the quarter ended December 31, 2011.

Cipla focuses on development of new formulations and has a wide range of pharmaceutical products. It offers prescription drugs, bulk drugs, animal products and pesticides. It also offers a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×